We are live on ! Find out more
SC

Schulhoff & Co Portfolio holdings

AUM $243M
1-Year Est. Return 17.47%
This Fund
S&P 500
This Quarter Est. Return
+3.51%
1 Year Est. Return
+17.47%
3 Year Est. Return
+42.69%
5 Year Est. Return
+58.83%
10 Year Est. Return
+178.36%
AUM
$238M
AUM Growth
+$3.32M
Cap. Flow
-$2.31M
Cap. Flow %
-0.97%
Top 10 Hldgs %
40.65%
Holding
138
New
3
Increased
34
Reduced
36
Closed
6

Sector Composition

Rank Sector Weight
1 Financials 21.72%
2 Consumer Staples 17.43%
3 Industrials 12.82%
4 Healthcare 12.68%
5 Technology 9.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTAS icon
126
Cintas
CTAS
$82.5B
-1,414
Closed -$290K
KHC icon
127
Kraft Heinz
KHC
$31.1B
-8,281
Closed -$216K
META icon
128
Meta Platforms (Facebook)
META
$1.69T
-344
Closed -$253K
PYXS icon
129
Pyxis Oncology
PYXS
$141M
-275,000
Closed -$611K
SLV icon
130
iShares Silver Trust
SLV
$27.1B
-10,400
Closed -$441K

Similar funds

Schulhoff & Co's Q4 2025 Portfolio in Review

As of Q4 2025, Schulhoff & Co held 138 positions worth $238M, up 1.4% from $234M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Schulhoff & Co's Q4 2025 filing shows 3 new, 34 increased, 36 reduced and 6 closed positions. Its largest new stake was CytomX Therapeutics: 374,850 shares worth $1.6M. The largest sale was Avadel Pharmaceuticals, an estimated $2.1M.

By sector, the portfolio is most concentrated in Financials at 22% of assets, up from 21% a quarter earlier, followed by Consumer Staples and Industrials.

  • Schulhoff & Co's largest Q4 2025 buy was CytomX Therapeutics: 374,850 shares worth $1.6M.
  • Schulhoff & Co added most to Sprott Physical Silver Trust in Q4 2025, an estimated $566K increase.
  • Schulhoff & Co's biggest Q4 2025 reduction was DuPont de Nemours, cutting an estimated $452K.
  • Schulhoff & Co fully exited Avadel Pharmaceuticals in Q4 2025, selling an estimated $2.1M.
  • Schulhoff & Co's ten largest holdings make up 41% of its $238M portfolio in Q4 2025.
  • Schulhoff & Co opened 3 new positions and closed 6 in Q4 2025.
  • Schulhoff & Co's portfolio value rose 1.4% quarter-over-quarter to $238M.

Based on Schulhoff & Co's 13F filing for Q4 2025, filed 11 Feb 2026.